You have 9 free searches left this month | for more free features.

City

Seoul (1)

Condition

Prostate Cancer (1)

Prostatic Neoplasms, Castration-Resistant (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Bayer (1)

Bukwang Pharmaceutical (1)

Collaborator

Dyna Therapeutics (1)

Intervention

zytiga (2)

radium ra 223 dichloride (xofigo, bay88-8223) (1)

sol-804-f (1)

xtandi (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (1)

Observational (1)

zytiga

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Prostate Cancer Trial in Seoul (SOL-804-F, Zytiga)

Recruiting

Prostate Cancer

SOL-804-F
Zytiga

Seoul, Korea, Republic of

Seoul National University Hospital

Aug 25, 2023

mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone

Withdrawn

Prostatic Neoplasms, Castration-Resistant

radium Ra 223 dichloride (Xofigo, BAY88-8223)
+2 more

(no location specified)

Oct 29, 2018